Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Author(s): Burak C. Sevim, Harleen Chela, Hamza Ertugrul, Lyiba S. Malik, Suha Malik, Omer Basar, Ebubekir Daglilar, Sami Samiullah, Ayman H. Gaballah and Veysel Tahan*

DOI: 10.2174/1871530322666220929142905

DownloadDownload PDF Flyer Cite As
Non-Alcoholic Fatty Pancreas Disease: The Unsung Disease

Page: [485 - 493] Pages: 9

  • * (Excluding Mailing and Handling)

Abstract

Non-alcoholic fatty pancreas disease (NAFPD) is a relatively new and emerging disease that is increasingly diagnosed yearly, like non-alcoholic fatty liver disease (NAFLD). It is associated especially with metabolic syndrome and obesity. As awareness of pancreatic steatosis and its clinical implications increase, it is diagnosed more frequently. The researchers have explained the clinical importance of NAFPD and the diseases it causes, such as pancreatitis, pancreatic insufficiency, and pancreatic cancer. Although the definitive treatment is not yet established, the primary treatment approach is weight loss since NAFPD is associated with metabolic syndrome as well as obesity. Although pharmacological agents, such as oral hypoglycemic agents, have been investigated in animal experiments, studies on humans have not been conducted. Since the research on NAFPD is still insufficient, it is a subject that needs to be investigated, and further studies are needed to explore its pathophysiology, clinical impact, and its management.

Keywords: Non-alcoholic, fatty, pancreas, nafpd, steatopancreatitis, obesity

Graphical Abstract

[1]
WHO. Obesity and overweight. 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
[2]
CDC. Data & statistics, adult obesity facts. Overweight & Obesity, 2021. Available from: https://www.cdc.gov/obesity/data/adult.html
[3]
Younossi, Z.M. Non-alcoholic fatty liver disease – A global public health perspective. J. Hepatol., 2019, 70(3), 531-544.
[http://dx.doi.org/10.1016/j.jhep.2018.10.033] [PMID: 30414863]
[4]
Sarwar, R.; Pierce, N.; Koppe, S. Obesity and nonalcoholic fatty liver disease: Current perspectives. Diabetes Metab. Syndr. Obes., 2018, 11, 533-542.
[http://dx.doi.org/10.2147/DMSO.S146339] [PMID: 30288073]
[5]
Romana, B.S.; Chela, H.; Dailey, F.E.; Nassir, F.; Tahan, V. Non-alcoholic fatty pancreas disease (NAFPD): A silent spectator or the fifth component of metabolic syndrome? A literature review. Endocr. Metab. Immune Disord. Drug Targets, 2018, 18(6), 547-554.
[http://dx.doi.org/10.2174/1871530318666180328111302] [PMID: 29595117]
[6]
Al Juboori, A.; Chela, H.; Samiullah, S.; Tahan, V. Non-alcoholic fatty pancreatic disease (NAFPD). In: Obesity and Diabetes: New Surgical and Nonsurgical Approaches; Joel, F.; Salomão, F., Eds.; Springer Nature: Switzerland AG, 2020; pp. 335-345.
[7]
Schaefer, J.H. The normal weight of the pancreas in the adult human being: A biometric study. Anat. Rec., 1926, 32(2), 119-132.
[http://dx.doi.org/10.1002/ar.1090320204]
[8]
Ogilvie, R.F. The islands of langerhans in 19 cases of obesity. J. Pathol. Bacteriol., 1933, 37(3), 473-481.
[http://dx.doi.org/10.1002/path.1700370314]
[9]
Olsen, T.S. Lipomatosis of the pancreas in autopsy material and its relation to age and overweight. Acta Pathol. Microbiol. Scand. [A], 1978, 86A(1-6), 367-373.
[http://dx.doi.org/10.1111/j.1699-0463.1978.tb02058.x] [PMID: 716899]
[10]
Stamm, B.H. Incidence and diagnostic significance of minor pathologic changes in the adult pancreas at autopsy. Hum. Pathol., 1984, 15(7), 677-683.
[http://dx.doi.org/10.1016/S0046-8177(84)80294-4] [PMID: 6745910]
[11]
Smits, M.M.; van Geenen, E.J.M. The clinical significance of pancreatic steatosis. Nat. Rev. Gastroenterol. Hepatol., 2011, 8(3), 169-177.
[http://dx.doi.org/10.1038/nrgastro.2011.4] [PMID: 21304475]
[12]
Wang, C.Y.; Ou, H.Y.; Chen, M.F.; Chang, T.C.; Chang, C.J. Enigmatic ectopic fat: Prevalence of nonalcoholic fatty pancreas disease and its associated factors in a Chinese population. J. Am. Heart Assoc., 2014, 3(1), e000297.
[http://dx.doi.org/10.1161/JAHA.113.000297] [PMID: 24572250]
[13]
Pham, Y.H.; Bingham, B.A.; Bell, C.S.; Greenfield, S.A.; John, S.D.; Robinson, L.H.; Eissa, M.A. Prevalence of Pancreatic Steatosis at a Pediatric Tertiary Care Center. South. Med. J., 2016, 109(3), 196-198.
[http://dx.doi.org/10.14423/SMJ.0000000000000432] [PMID: 26954660]
[14]
Singh, R.G.; Yoon, H.D.; Wu, L.M.; Lu, J.; Plank, L.D.; Petrov, M.S. Ectopic fat accumulation in the pancreas and its clinical relevance: A systematic review, meta-analysis, and meta-regression. Metabolism, 2017, 69, 1-13.
[http://dx.doi.org/10.1016/j.metabol.2016.12.012] [PMID: 28285638]
[15]
Szczepaniak, L.S.; Victor, R.G.; Mathur, R.; Nelson, M.D.; Szczepaniak, E.W.; Tyer, N.; Chen, I.; Unger, R.H.; Bergman, R.N.; Lingvay, I. Pancreatic steatosis and its relationship to β-cell dysfunction in humans: Racial and ethnic variations. Diabetes Care, 2012, 35(11), 2377-2383.
[http://dx.doi.org/10.2337/dc12-0701] [PMID: 22968187]
[16]
Lê, K.A.; Ventura, E.E.; Fisher, J.Q.; Davis, J.N.; Weigensberg, M.J.; Punyanitya, M.; Hu, H.H.; Nayak, K.S.; Goran, M.I. Ethnic differences in pancreatic fat accumulation and its relationship with other fat depots and inflammatory markers. Diabetes Care, 2011, 34(2), 485-490.
[http://dx.doi.org/10.2337/dc10-0760] [PMID: 21270204]
[17]
Carter, R.; Mouralidarane, A.; Soeda, J.; Ray, S.; Pombo, J.; Saraswati, R.; Novelli, M.; Fusai, G.; Rappa, F.; Saracino, C.; Pazienza, V.; Poston, L.; Taylor, P.D.; Vinciguerra, M.; Oben, J.A. Non-alcoholic fatty pancreas disease pathogenesis: A role for developmental programming and altered circadian rhythms. PLoS One, 2014, 9(3), e89505.
[http://dx.doi.org/10.1371/journal.pone.0089505] [PMID: 24657938]
[18]
Gyllenhammer, L.E.; Alderete, T.L.; Toledo-Corral, C.M.; Weigensberg, M.; Goran, M.I. Saturation of subcutaneous adipose tissue expansion and accumulation of ectopic fat associated with metabolic dysfunction during late and post-pubertal growth. Int. J. Obes., 2016, 40(4), 601-606.
[19]
Sattar, N.; Gill, J.M.R. Type 2 diabetes as a disease of ectopic fat? BMC Med., 2014, 12(1), 123.
[http://dx.doi.org/10.1186/s12916-014-0123-4] [PMID: 25159817]
[20]
Yu, T.Y.; Wang, C.Y. Impact of non-alcoholic fatty pancreas disease on glucose metabolism. J. Diabetes Investig., 2017, 8(6), 735-747.
[http://dx.doi.org/10.1111/jdi.12665] [PMID: 28371475]
[21]
Feldman, M.; Friedman, L.S.; Brandt, L.J. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease, 10th ed; Elsevier: Philadelphia, 2016, pp. 1428-1441.
[22]
Pinnick, K.E.; Collins, S.C.; Londos, C.; Gauguier, D.; Clark, A.; Fielding, B.A. Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition. Obesity (Silver Spring), 2008, 16(3), 522-530.
[http://dx.doi.org/10.1038/oby.2007.110] [PMID: 18239594]
[23]
Fraulob, J.C.; Ogg-Diamantino, R.; Fernandes-Santos, C.; Aguila, M.B.; Mandarim-de-Lacerda, C.A. A mouse model of metabolic syndrome: Insulin resistance, fatty liver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL/6 mice fed a high fat diet. J. Clin. Biochem. Nutr., 2010, 46(3), 212-223.
[http://dx.doi.org/10.3164/jcbn.09-83] [PMID: 20490316]
[24]
Sepe, P.S.; Ohri, A.; Sanaka, S.; Berzin, T.M.; Sekhon, S.; Bennett, G.; Mehta, G.; Chuttani, R.; Kane, R.; Pleskow, D.; Sawhney, M.S. A prospective evaluation of fatty pancreas by using EUS. Gastrointest. Endosc., 2011, 73(5), 987-993.
[http://dx.doi.org/10.1016/j.gie.2011.01.015] [PMID: 21521567]
[25]
Ogiu, N.; Nakamura, Y.; Ijiri, I.; Hiraiwa, K.; Ogiu, T. A statistical analysis of the internal organ weights of normal Japanese people. Health Phys., 1997, 72(3), 368-383.
[http://dx.doi.org/10.1097/00004032-199703000-00004] [PMID: 9030838]
[26]
Saisho, Y.; Butler, A.E.; Meier, J.J.; Monchamp, T.; Allen-Auerbach, M.; Rizza, R.A.; Butler, P.C. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type‐2 diabetes. Clin. Anat., 2007, 20(8), 933-942.
[http://dx.doi.org/10.1002/ca.20543] [PMID: 17879305]
[27]
Chantarojanasiri, T.; Hirooka, Y.; Ratanachu-Ek, T.; Kawashima, H.; Ohno, E.; Goto, H. Evolution of pancreas in aging: Degenerative variation or early changes of disease? J. Med. Ultrason., 2015, 42(2), 177-183.
[28]
Glaser, J.; Stienecker, K. Pancreas and aging: A study using ultrasonography. Gerontology, 2000, 46(2), 93-96.
[http://dx.doi.org/10.1159/000022141] [PMID: 10671806]
[29]
Reaven, G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes, 1988, 37(12), 1595-1607.
[http://dx.doi.org/10.2337/diab.37.12.1595] [PMID: 3056758]
[30]
Kaur, J. A comprehensive review on metabolic syndrome. Cardiol. Res. Pract., 2014, 2014, 1-21.
[http://dx.doi.org/10.1155/2014/943162] [PMID: 24711954]
[31]
Olufadi, R.; Byrne, C.D. Clinical and laboratory diagnosis of the metabolic syndrome. J. Clin. Pathol., 2007, 61(6), 697-706.
[http://dx.doi.org/10.1136/jcp.2007.048363] [PMID: 18505888]
[32]
Perumpail, R.B.; Wong, R.J.; Ahmed, A.; Harrison, S.A. Hepatocellular carcinoma in the setting of non-cirrhotic nonalcoholic fatty liver disease and the metabolic syndrome: US experience. Dig. Dis. Sci., 2015, 60(10), 3142-3148.
[http://dx.doi.org/10.1007/s10620-015-3821-7] [PMID: 26250831]
[33]
Wu, W.C.; Wang, C.Y. Association between non-alcoholic fatty pancreatic disease (nafpd) and the metabolic syndrome: Case–control retrospective study. Cardiovasc. Diabetol., 2013, 12(1), 77.
[http://dx.doi.org/10.1186/1475-2840-12-77] [PMID: 23688357]
[34]
Choi, C.W.; Kim, G.H.; Kang, D.H.; Kim, H.W.; Kim, D.U.; Heo, J.; Song, G.A.; Park, D.Y.; Kim, S. Associated factors for a hyperechogenic pancreas on endoscopic ultrasound. World J. Gastroenterol., 2010, 16(34), 4329-4334.
[http://dx.doi.org/10.3748/wjg.v16.i34.4329] [PMID: 20818817]
[35]
van Raalte, D.H.; van der Zijl, N.J.; Diamant, M. Pancreatic steatosis in humans: Cause or marker of lipotoxicity? Curr. Opin. Clin. Nutr. Metab. Care, 2010, 13(4), 478-485.
[36]
Heni, M.; Machann, J.; Staiger, H.; Schwenzer, N.F.; Peter, A.; Schick, F.; Claussen, C.D.; Stefan, N.; Häring, H.U.; Fritsche, A. Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: A nuclear magnetic resonance study. Diabetes Metab. Res. Rev., 2010, 26(3), 200-205.
[http://dx.doi.org/10.1002/dmrr.1073] [PMID: 20225188]
[37]
Zhao, Z.; Xin, L.; Xia, J.; Yang, S.; Chen, Y.; Li, K. Long-term high-fat high-sucrose diet promotes enlarged islets and β-cell damage by oxidative stress in bama minipigs. Pancreas, 2015, 44(6), 888-895.
[http://dx.doi.org/10.1097/MPA.0000000000000349] [PMID: 25906446]
[38]
Ræder, H.; Haldorsen, I.S.; Ersland, L.; Grüner, R.; Taxt, T.; Søvik, O.; Molven, A.; Njølstad, P.R. Pancreatic lipomatosis is a structural marker in nondiabetic children with mutations in carboxyl-ester lipase. Diabetes, 2007, 56(2), 444-449.
[http://dx.doi.org/10.2337/db06-0859] [PMID: 17259390]
[39]
Wong, V.W.S.; Wong, G.L.H.; Yeung, D.K.W.; Abrigo, J.M.; Kong, A.P.S.; Chan, R.S.M.; Chim, A.M.L.; Shen, J.; Ho, C.S.; Woo, J.; Chu, W.C.W.; Chan, H.L.Y. Fatty pancreas, insulin resistance, and β-cell function: A population study using fat-water magnetic resonance imaging. Am. J. Gastroenterol., 2014, 109(4), 589-597.
[http://dx.doi.org/10.1038/ajg.2014.1] [PMID: 24492753]
[40]
Della Corte, C.; Mosca, A.; Majo, F.; Lucidi, V.; Panera, N.; Giglioni, E.; Monti, L.; Stronati, L.; Alisi, A.; Nobili, V. Nonalcoholic fatty pancreas disease and Nonalcoholic fatty liver disease: More than ectopic fat. Clin. Endocrinol. (Oxf.), 2015, 83(5), 656-662.
[http://dx.doi.org/10.1111/cen.12862] [PMID: 26201937]
[41]
Lee, J.S.; Kim, S.H.; Jun, D.W.; Han, J.H.; Jang, E.C.; Park, J.Y.; Son, B.K.; Kim, S.H.; Jo, Y.J.; Park, Y.S.; Kim, Y.S. Clinical implications of fatty pancreas: Correlations between fatty pancreas and metabolic syndrome. World J. Gastroenterol., 2009, 15(15), 1869-1875.
[http://dx.doi.org/10.3748/wjg.15.1869] [PMID: 19370785]
[42]
Tariq, H.; Nayudu, S.; Akella, S.; Glandt, M.; Chilimuri, S. Non-alcoholic fatty pancreatic disease: A review of literature. Gastroenterol. Res., 2016, 9(6), 87-91.
[http://dx.doi.org/10.14740/gr731w] [PMID: 28058076]
[43]
Volk, B.; New, P. The Diabetic Pancreas, 1st ed; Plenum Press: New York, 1977, pp. 317-324.
[44]
Sasaki, M.; Nakanuma, Y.; Ando, H. Lipomatous pseudohypertrophy of the pancreas in a patient with cirrhosis due to chronic hepatitis B. Pathol. Int., 1998, 48(7), 566-568.
[http://dx.doi.org/10.1111/j.1440-1827.1998.tb03951.x] [PMID: 9701022]
[45]
Walters, M.N-I. Adipose atrophy of the exocrine pancreas. J. Pathol. Bacteriol., 1966, 92(2), 547-557.
[http://dx.doi.org/10.1002/path.1700920232] [PMID: 5964381]
[46]
Catanzaro, R.; Cuffari, B.; Italia, A.; Marotta, F. Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease. World J. Gastroenterol., 2016, 22(34), 7660-7675.
[http://dx.doi.org/10.3748/wjg.v22.i34.7660] [PMID: 27678349]
[47]
Fernandes-Santos, C.; Evangelista Carneiro, R.; de Souza Mendonca, L.; Barbosa Águila, M.; Alberto Mandarim-de-Lacerda, C. Rosiglitazone aggravates nonalcoholic Fatty pancreatic disease in C57BL/6 mice fed high-fat and high-sucrose diet. Pancreas, 2009, 38(3), e80-e86.
[http://dx.doi.org/10.1097/MPA.0b013e3181987d9d] [PMID: 19214135]
[48]
Chehter, E.Z.; Longo, M.A.; Laudanna, A.A.; Duarte, M.I.S. Involvement of the pancreas in AIDS: A prospective study of 109 post-mortems. AIDS, 2000, 14(13), 1879-1886.
[http://dx.doi.org/10.1097/00002030-200009080-00001] [PMID: 10997390]
[49]
Tham, R.T.; Heyerman, H.G.; Falke, T.H.; Zwinderman, A.H.; Bloem, J.L.; Bakker, W.; Lamers, C.B. Cystic fibrosis: MR imaging of the pancreas. Radiology, 1991, 179(1), 183-186.
[http://dx.doi.org/10.1148/radiology.179.1.2006275] [PMID: 2006275]
[50]
Murayama, S.; Robinson, A.E.; Mulvihill, D.M.; Goyco, P.G.; Beckerman, R.C.; Hines, M.R.; Stallworth, J.M. MR imaging of pancreas in cystic fibrosis. Pediatr. Radiol., 1990, 20(7), 536-539.
[http://dx.doi.org/10.1007/BF02011384] [PMID: 2216589]
[51]
Fiel, S.B.; Friedman, A.C.; Caroline, D.F.; Radecki, P.D.; Faerber, E.; Grumbach, K. Magnetic resonance imaging in young adults with cystic fibrosis. Chest, 1987, 91(2), 181-184.
[http://dx.doi.org/10.1378/chest.91.2.181] [PMID: 3542402]
[52]
Jones, J.S. Adult cystic fibrosis (mucoviscidosis). Fatty replacement of the pancreas in a woman aged 47 years. Br. J. Dis. Chest, 1970, 64(1), 25-36.
[PMID: 5438755]
[53]
Çubuk, M.; Arslan, G.; Çeken, K.; Özkaynak, C.; Lüleci, E. Schwachman-diamond syndrome: A case report. Acta Radiol., 2000, 41(6), 627-628.
[http://dx.doi.org/10.1080/028418500127346036] [PMID: 11092487]
[54]
Lee, J.H.; Bae, S.H.; Yu, J.J.; Lee, R.; Yun, Y.M.; Song, E.Y. A case of Shwachman-Diamond syndrome confirmed with genetic analysis in a Korean child. J. Korean Med. Sci., 2008, 23(1), 142-145.
[http://dx.doi.org/10.3346/jkms.2008.23.1.142] [PMID: 18303216]
[55]
Daentl, D.L.; Frías, J.L.; Gilbert, E.F.; Opitz, J.M.; Kaye, C. The Johanson-Blizzard syndrome: Case report and autopsy findings. Am. J. Med. Genet., 1979, 3(2), 129-135.
[http://dx.doi.org/10.1002/ajmg.1320030203] [PMID: 474625]
[56]
Diamond, I.; Vallbona, C. Kwashiorkor in a North American white male. Pediatrics, 1960, 25(2), 248-257.
[http://dx.doi.org/10.1542/peds.25.2.248] [PMID: 13816524]
[57]
López, J.M.; Bombi, J.A.; Valderrama, R.; Giménez, A.; Parés, A.; Caballería, J.; Imperial, S.; Navarro, S. Effects of prolonged ethanol intake and malnutrition on rat pancreas. Gut, 1996, 38(2), 285-292.
[http://dx.doi.org/10.1136/gut.38.2.285] [PMID: 8801213]
[58]
Pinte, L.; Balaban, D.V.; Băicuş, C.; Jinga, M. Non-alcoholic fatty pancreas disease – practices for clinicians. Rom. J. Intern. Med., 2019, 57(3), 209-219.
[http://dx.doi.org/10.2478/rjim-2019-0005] [PMID: 30901317]
[59]
Grundy, S. Then and now: ATP III vs. IV - American College of Cardiology. 2013. Available from: https://www.acc.org/latest-in cardiology/articles/2014/07/18/16/03/then-and-now-atp-iii-vs-iv
[60]
Al-Haddad, M.; Khashab, M.; Zyromski, N.; Pungpapong, S.; Wallace, M.B.; Scolapio, J.; Woodward, T.; Noh, K.; Raimondo, M. Risk factors for hyperechogenic pancreas on endoscopic ultrasound: A case-control study. Pancreas, 2009, 38(6), 672-675.
[http://dx.doi.org/10.1097/MPA.0b013e3181a9d5af] [PMID: 19506531]
[61]
Marks, W.M.; Filly, R.A.; Callen, P.W. Ultrasonic evaluation of normal pancreatic echogenicity and its relationship to fat deposition. Radiology, 1980, 137(2), 475-479.
[http://dx.doi.org/10.1148/radiology.137.2.7433680] [PMID: 7433680]
[62]
Ustundag, Y.; Ceylan, G.; Hekimoglu, K. Pancreatic hyperechogenicity on endoscopic ultrasound examination. World J. Gastroenterol., 2011, 17(15), 2061-2062.
[http://dx.doi.org/10.3748/wjg.v17.i15.2061] [PMID: 21528089]
[63]
Begovatz, P.; Koliaki, C.; Weber, K.; Strassburger, K.; Nowotny, B.; Nowotny, P.; Müssig, K.; Bunke, J.; Pacini, G.; Szendrödi, J.; Roden, M. Pancreatic adipose tissue infiltration, parenchymal steatosis and beta cell function in humans. Diabetologia, 2015, 58(7), 1646-1655.
[http://dx.doi.org/10.1007/s00125-015-3544-5] [PMID: 25740696]
[64]
Hague, J.; Amin, Z. Focal pancreatic lesion: Can a neoplasm be confidently excluded? Br. J. Radiol., 2006, 79(943), 627-629.
[http://dx.doi.org/10.1259/bjr/19356841] [PMID: 16823069]
[65]
Kim, S.Y.; Kim, H.; Cho, J.Y.; Lim, S.; Cha, K.; Lee, K.H.; Kim, Y.H.; Kim, J.H.; Yoon, Y.S.; Han, H.S.; Kang, H.S. Quantitative assessment of pancreatic fat by using unenhanced CT: Pathologic correlation and clinical implications. Radiology, 2014, 271(1), 104-112.
[http://dx.doi.org/10.1148/radiol.13122883] [PMID: 24475851]
[66]
Pezzilli, R.; Calculli, L. Pancreatic steatosis: Is it related to either obesity or diabetes mellitus? World J. Diabetes, 2014, 5(4), 415-419.
[http://dx.doi.org/10.4239/wjd.v5.i4.415] [PMID: 25126389]
[67]
Lee, Y.; Lingvay, I.; Szczepaniak, L.S.; Ravazzola, M.; Orci, L.; Unger, R.H. Pancreatic steatosis: Harbinger of type 2 diabetes in obese rodents. Int. J. Obes., 2010, 34(2), 396-400.
[68]
Lingvay, I.; Esser, V.; Legendre, J.L.; Price, A.L.; Wertz, K.M.; Adams-Huet, B.; Zhang, S.; Unger, R.H.; Szczepaniak, L.S. Noninvasive quantification of pancreatic fat in humans. J. Clin. Endocrinol. Metab., 2009, 94(10), 4070-4076.
[http://dx.doi.org/10.1210/jc.2009-0584] [PMID: 19773401]
[69]
Hu, H.H.; Kim, H.W.; Nayak, K.S.; Goran, M.I. Comparison of fat-water MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans. Obesity (Silver Spring), 2010, 18(4), 841-847.
[http://dx.doi.org/10.1038/oby.2009.352] [PMID: 19834463]
[70]
Kul, S.; Karadeniz, A.; Dursun, İ.; Şahin, S.; Faruk Çırakoğlu, Ö.; Raşit Sayın, M.; Turan, T.; el al Hakan Ateş, A. Non-alcoholic fatty pancreas disease is associated with increased epicardial adipose tissue and aortic intima-media thickness. Zhonghua Minguo Xinzangxue Hui Zazhi, 2019, 35(2), 118-125.
[PMID: 30930559]
[71]
Ou, H.Y.; Wang, C.Y.; Yang, Y.C.; Chen, M.F.; Chang, C.J. The association between nonalcoholic fatty pancreas disease and diabetes. PLoS One, 2013, 8(5), e62561.
[http://dx.doi.org/10.1371/journal.pone.0062561] [PMID: 23671610]
[72]
Alberti, K.G.M.M.; Eckel, R.H.; Grundy, S.M.; Zimmet, P.Z.; Cleeman, J.I.; Donato, K.A.; Fruchart, J.C.; James, W.P.T.; Loria, C.M.; Smith, S.C., Jr Harmonizing the metabolic syndrome. Circulation, 2009, 120(16), 1640-1645.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.109.192644] [PMID: 19805654]
[73]
Bi, Y.; Wang, J.L.; Li, M.L.; Zhou, J.; Sun, X.L. The association between pancreas steatosis and metabolic syndrome: A systematic review and meta‐analysis. Diabetes Metab. Res. Rev., 2019, 35(5), e3142.
[http://dx.doi.org/10.1002/dmrr.3142] [PMID: 30767421]
[74]
Martinez, J.; Johnson, C.D.; Sanchez-Paya, J.; de Madaria, E.; Robles-Diaz, G.; Perez-Mateo, M. Obesity is a definitive risk factor of severity and mortality in acute pancreatitis: An updated meta-analysis. Pancreatology, 2006, 6(3), 206-209.
[75]
Papachristou, G.I.; Papachristou, D.J.; Avula, H.; Slivka, A.; Whitcomb, D.C. Obesity increases the severity of acute pancreatitis: Performance of APACHE-O score and correlation with the inflammatory response. Pancreatology, 2006, 6(4), 279-285.
[76]
Yan, M.X.; Li, Y.Q.; Meng, M.; Ren, H.B.; Kou, Y. Long-term high-fat diet induces pancreatic injuries via pancreatic microcirculatory disturbances and oxidative stress in rats with hyperlipidemia. Biochem. Biophys. Res. Commun., 2006, 347(1), 192-199.
[http://dx.doi.org/10.1016/j.bbrc.2006.06.063] [PMID: 16814251]
[77]
Mathur, A.; Marine, M.; Lu, D.; Swartz-Basile, D.A.; Saxena, R.; Zyromski, N.J.; Pitt, H.A. Nonalcoholic fatty pancreas disease. HPB (Oxford), 2007, 9(4), 312-318.
[http://dx.doi.org/10.1080/13651820701504157] [PMID: 18345311]
[78]
Acharya, C.; Cline, R.A.; Jaligama, D.; Noel, P.; Delany, J.P.; Bae, K.; Furlan, A.; Baty, C.J.; Karlsson, J.M.; Rosario, B.L.; Patel, K.; Mishra, V.; Dugampudi, C.; Yadav, D.; Navina, S.; Singh, V.P. Fibrosis reduces severity of acute-on-chronic pancreatitis in humans. Gastroenterology, 2013, 145(2), 466-475.
[http://dx.doi.org/10.1053/j.gastro.2013.05.012] [PMID: 23684709]
[79]
Navina, S.; Acharya, C.; DeLany, J. Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity. Sci. Transl. Med., 2011, 3(107), 110.
[http://dx.doi.org/10.1126/scitranslmed.3002573]
[80]
de Gonzalez, A.B.; Sweetland, S.; Spencer, E. A meta-analysis of obesity and the risk of pancreatic cancer. Br. J. Cancer, 2003, 89(3), 519-523.
[http://dx.doi.org/10.1038/sj.bjc.6601140] [PMID: 12888824]
[81]
Preziosi, G.; Oben, J.A.; Fusai, G. Obesity and pancreatic cancer. Surg. Oncol., 2014, 23(2), 61-71.
[http://dx.doi.org/10.1016/j.suronc.2014.02.003] [PMID: 24746917]
[82]
Hori, M.; Takahashi, M.; Hiraoka, N.; Yamaji, T.; Mutoh, M.; Ishigamori, R.; Furuta, K.; Okusaka, T.; Shimada, K.; Kosuge, T.; Kanai, Y.; Nakagama, H. Association of pancreatic Fatty infiltration with pancreatic ductal adenocarcinoma. Clin. Transl. Gastroenterol., 2014, 5(3), e53.
[http://dx.doi.org/10.1038/ctg.2014.5] [PMID: 24622469]
[83]
Mathur, A.; Zyromski, N.J.; Pitt, H.A.; Al-Azzawi, H.; Walker, J.J.; Saxena, R.; Lillemoe, K.D. Pancreatic steatosis promotes dissemination and lethality of pancreatic cancer. J. Am. Coll. Surg., 2009, 208(5), 989-994.
[http://dx.doi.org/10.1016/j.jamcollsurg.2008.12.026] [PMID: 19476877]
[84]
Lesmana, C.R.A.; Gani, R.A.; Lesmana, L.A. Non-Alcoholic Fatty Pancreas Disease (NAFPD) as risk factor for pancreatic cancer based on Endoscopic Ultrasound (EUS) examination: A single center experience. Gastroenterology, 2017, 152(5), S897.
[http://dx.doi.org/10.1016/S0016-5085(17)33066-4]
[85]
Pezzilli, R.; Andriulli, A.; Bassi, C.; Balzano, G.; Cantore, M.; Delle Fave, G.; Falconi, M. Exocrine pancreatic insufficiency in adults: A shared position statement of the Italian association for the study of the pancreas. World J. Gastroenterol., 2013, 19(44), 7930-7946.
[http://dx.doi.org/10.3748/wjg.v19.i44.7930] [PMID: 24307787]
[86]
Tahtaci, M.; Algin, O.; Karakan, T.; Tayfur Yurekli, O.; Alışık, M.; Köseoglu, H.; Rusen Metin, M.; Demirezer Bolat, A.; Erel, O.; Ersoy, O. Can pancreatic steatosis affect exocrine functions of pancreas? Turk. J. Gastroenterol., 2018, 29(5), 588-594.
[http://dx.doi.org/10.5152/tjg.2018.17696] [PMID: 30260782]
[87]
Mathur, A.; Pitt, H.A.; Marine, M.; Saxena, R.; Schmidt, C.M.; Howard, T.J.; Nakeeb, A.; Zyromski, N.J.; Lillemoe, K.D. Fatty pancreas. Ann. Surg., 2007, 246(6), 1058-1064.
[http://dx.doi.org/10.1097/SLA.0b013e31814a6906] [PMID: 18043111]
[88]
Hanish, S.I.; Petersen, R.P.; Collins, B.H.; Tuttle-Newhall, J.; Marroquin, C.E.; Kuo, P.C.; Butterly, D.W.; Smith, S.R.; Desai, D.M. Obesity predicts increased overall complications following pancreas transplantation. Transplant. Proc., 2005, 37(8), 3564-3566.
[http://dx.doi.org/10.1016/j.transproceed.2005.09.068] [PMID: 16298662]
[89]
Honka, H.; Koffert, J.; Hannukainen, J.C.; Tuulari, J.J.; Karlsson, H.K.; Immonen, H.; Oikonen, V.; Tolvanen, T.; Soinio, M.; Salminen, P.; Kudomi, N.; Mari, A.; Iozzo, P.; Nuutila, P. The effects of bariatric surgery on pancreatic lipid metabolism and blood flow. J. Clin. Endocrinol. Metab., 2015, 100(5), 2015-2023.
[http://dx.doi.org/10.1210/jc.2014-4236] [PMID: 25734253]
[90]
Lim, E.L.; Hollingsworth, K.G.; Aribisala, B.S.; Chen, M.J.; Mathers, J.C.; Taylor, R. Reversal of type 2 diabetes: Normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia, 2011, 54(10), 2506-2514.
[http://dx.doi.org/10.1007/s00125-011-2204-7] [PMID: 21656330]
[91]
Steven, S.; Hollingsworth, K.G.; Small, P.K.; Woodcock, S.A.; Pucci, A.; Aribisala, B.; Al-Mrabeh, A.; Daly, A.K.; Batterham, R.L.; Taylor, R. Weight loss decreases excess pancreatic triacylglycerol specifically in type 2 diabetes. Diabetes Care, 2016, 39(1), 158-165.
[http://dx.doi.org/10.2337/dc15-0750] [PMID: 26628414]
[92]
Piro, S.; Rabuazzo, A.M.; Renis, M.; Purrello, F. Effects of metformin on oxidative stress, adenine nucleotides balance, and glucose-induced insulin release impaired by chronic free fatty acids exposure in rat pancreatic islets. J. Endocrinol. Invest., 2012, 35(5), 504-510.
[PMID: 21750398]
[93]
Tajima, K.; Shirakawa, J.; Okuyama, T.; Kyohara, M.; Yamazaki, S.; Togashi, Y.; Terauchi, Y. Effects of metformin on compensatory pancreatic β-cell hyperplasia in mice fed a high-fat diet. Am. J. Physiol. Endocrinol. Metab., 2017, 313(3), E367-E380.
[http://dx.doi.org/10.1152/ajpendo.00447.2016] [PMID: 28512156]
[94]
Jia, D.M.; Fukumitsu, K.I.; Tabaru, A.; Akiyama, T.; Otsuki, M. Troglitazone stimulates pancreatic growth in congenitally CCK-A receptor-deficient OLETF rats. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2001, 280(5), R1332-R1340.
[http://dx.doi.org/10.1152/ajpregu.2001.280.5.R1332] [PMID: 11294751]
[95]
Reimer, R.A.; Grover, G.J.; Koetzner, L.; Gahler, R.J.; Lyon, M.R.; Wood, S. Combining sitagliptin/metformin with a functional fiber delays diabetes progression in Zucker rats. J. Endocrinol., 2014, 220(3), 361-373.
[http://dx.doi.org/10.1530/JOE-13-0484] [PMID: 24389593]